MED EIBY Holding Co., Ltd. is a holding company. (Incorporated in the Cayman Islands)

MED EIBY Holding Co., Ltd., also known as Bestman, conducts its medical device manufacturing and export business through two operating entities in the People’s Republic of China:

-Shenzhen Bestman Precision Instruments Co. makes and sells Class I and Class II medical devices under its own brands: fetal dopplers, fetal/maternal monitors, ultrasonic vascular doppler detectors, vine finders and feeding pumps.

-Nanjing Yonglei, which exports Class I and Class II medical devices. 

**Note: On Feb. 22, 2023, MED EIBY’s shareholders and board of directors approved a forward split of our outstanding ordinary shares at a ratio of 500-for-1 share. 

The PRC operating entities sell their products both domestically and internationally. Besides significant domestic sales in China, the PRC operating entities’ export sales have expanded to more than 100 countries across the world.

Yong Bai, our founder and chief engineer, has served as our chairman of the Board of Directors and our CEO since May 25, 2022. He founded Shenzhen Bestman in August 2001. He has extensive experience of over 30 years in the medical device industry. Mr. Bai was one of the drafters of the YY0164 ultrasound doppler monitor standards. 

Yufang Li has served as our CFO since May 25, 2022. Ms. Li joined Shenzhen Bestman in February 2018 as an accountant and later assumed the position of the lead accountant.  From July 2016 to July 2017, Ms. Li worked for Hengqi Education Co., Ltd., an education agency, as an accountant. 

Note: Net loss and revenue figures are in U.S. dollars for the fiscal year that ended June 30, 2024. 

(Note:: MED EIBY Holding Co., Ltd., aka Bestman, filed an F-1/A dated Nov. 1, 2024, disclosing that Benjamin Securities and Prime Number Capital have been named joint book-runners, replacing Boustead Securities, the sole book-runner in the initial filing. MED EIBY Holding Co. Ltd. also reported its financial results for the fiscal year that ended June 30, 2024, in its F-1/A filing dated Nov. 1, 2024.)

(Note: MED EIBY Holding Co., Ltd., aka Bestman, filed an F-1/A dated Nov. 9, 2023, in which it tweaked its IPO’s terms by stating that the price range was $4.00 to $6.00 – a change from the assumed IPO price of $5.00 in the original terms. The number of shares – 4.0 million – remained the same. Background: MED EIBY Holding Co., Ltd., aka Bestman, filed its F-1 and disclosed its IPO terms on Feb. 24, 2023.)